Please enable JS

ARTICLES & TESTIMONIALS

FILTER BY TYPE

Most Recent

Categories

ARCHIVES

Amgen Just Slashed Its Price of the Cholesterol-Lowering Drug Repatha. So What Does This Mean for You?

Oct 29/Lauren Gelman/ PCSK9i

You may have heard that Amgen, which manufactures the cholesterol-lowering drug evolocumab (Repatha), just announced it is lowering the list price of the drug by about 60 percent to $5,850 per year from its original list price of $14,523. The company says that the goal of the price drop is to help lower patients’ copays, […]

READ MORE

New York Proclaims June as Migraine and Headache Awareness Month

Jun 05/50SN Staff/ Migraine

New York State Proclaims June as Migraine Awareness Month.

READ MORE

New Migraine Drug Approved. But Will Our Insurance Cover it?

May 18/50SN Staff/ Migraine

The U.S. Food and Drug Administration announced the approval of a new preventive migraine treatment.

READ MORE

Rheumatoid Arthritis Activism Produces Resilience and Other Rewards

Mar 30/50SN Staff/ Advocacy Testimony

Advocating for collective health issues may help you pursue your own care, fuel well-being, and more. https://www.everydayhealth.com/rheumatoid-arthritis/living-with/rheumatoid-arthritis-activism-produces-resilience/

READ MORE

What Patients Need to Know About Biosimilars

Mar 30/50SN Staff/ Biosimilars

Seth Ginsberg, co-founder and president of the Global Healthy Living Foundation, explains what patients should know about biosimilar therapies. http://www.centerforbiosimilars.com/interviews/seth-ginsberg-what-patients-need-to-know-about-biosimilars

READ MORE